References
- Minlikeeva AN, Moysich KB. An aspirin a day keeps ovarian cancer at bay? Expert Rev Anticancer Ther. 2019; 19(7):541–2.
- Seewaldt VL. Aspirin and chemoprevention-have we arrived? JAMA Oncol. 2018; 4(12):1668–9. doi:10.1001/jamaoncol.2018.4138.
- Wield AM, Walsh CS, Rimel BJ, Cass I, Karlan BY, Li AJ. Aspirin use correlates with survival in women with clear cell ovarian cancer. Gynecol Oncol Rep. 2018;25:78–81. doi:10.1016/j.gore.2018.06.004.
- Jin M, Li C, Zhang Q, Xing S, Kan X, Wang J. Effects of aspirin on proliferation, invasion and apoptosis of Hep-2 cells via the PTEN/AKT/NF-κB/survivin signaling pathway. Oncol Lett. 2018;15(6):8454–60. doi:10.3892/ol.2018.8377.
- Jiang JH, Lv QY, Yi YX, Liao J, Wang XW, Zhang W. MicroRNA-200a promotes proliferation and invasion of ovarian cancer cells by targeting PTEN. Eur Rev Med Pharmacol Sci. 2018;22(19):6260–7.
- Russo A, Czarnecki AA, Dean M, Modi DA, Lantvit DD, Hardy L, et al. PTEN loss in the fallopian tube induces hyperplasia and ovarian tumor formation. Oncogene. 2018;37(15):1976–90. doi:10.1038/s41388-017-0097-8.
- He X, Yang K, Wang H, Chen X, Wu H, Yao L, et al. Expression and clinical significance of survivin in ovarian cancer: a meta-analysis. PLoS One. 2018;13(5):e0194463. doi:10.1371/journal.pone.0194463.
- Yanagisawa S, Baker JR, Vuppusetty C, Fenwick P, Donnelly LE, Ito K, et al. Decreased phosphatase PTEN amplifies PI3K signaling and enhances proinflammatory cytokine release in COPD. Am J Physiol Lung Cell Mol Physiol. 2017;313(2):L230–9. doi:10.1152/ajplung.00382.2016.
- Browning L, Patel MR, Horvath EB, Tawara K, Jorcyk CL. IL-6 and ovarian cancer: inflammatory cytokines in promotion of metastasis. CMAR.. 2018; 10:6685–93. doi:10.2147/CMAR.S179189.
- Westfall SD, Skinner MK. Inhibition of phosphatidylinositol 3-kinase sensitizes ovarian cancer cells to carboplatin and allows adjunct chemotherapy treatment. Mol Cancer Ther. 2005;4(11):1764–71. doi:10.1158/1535-7163.MCT-05-0192.